US Patent Issued to NANJING RUIJIE PHARMA on Aug. 12 for "ACC inhibitor and use thereof" (Chinese Inventors)

ALEXANDRIA, Va., Aug. 12 -- United States Patent no. 12,384,798, issued on Aug. 12, was assigned to NANJING RUIJIE PHARMA Co. LTD (Jiangsu, China).

"ACC inhibitor and use thereof" was invented by Junbo Zhang (Jiangsu, China), Shuhao Zhu (Jiangsu, China) and Xiaoxin Qi (Jiangsu, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides a compound suitable for use as an acetyl CoA carboxylase (ACC) inhibitor, specifically, a thienopyridine derivative, and use of the compound in the preparation of drugs for treating metabolic disorders, cancers or other proliferative disorders, and nonalcoholic steatohepatitis (NASH)."

The patent was filed on Nov. 6, 2020, under Application No. 17/774...